Rizzo Stanislao, Genovesi-Ebert Federica, Murri Simona, Belting Claudia, Vento Andrea, Cresti Federica, Manca Maria Laura
Santa Chiara Hospital, Eye Surgery Clinic, Via Roma 67, 56100, Pisa, Italy.
Graefes Arch Clin Exp Ophthalmol. 2006 Apr;244(4):472-9. doi: 10.1007/s00417-005-0173-6. Epub 2006 Jan 19.
The aim of the study was to evaluate the safety and functional outcome of a small incision, sutureless vitrectomy in the treatment of idiopathic epiretinal membranes (ERM) compared with a standard 20-gauge vitrectomy system.
Forty-six consecutive patients with idiopathic ERM were recruited for this study and prospectively evaluated. In group 1 (n=26) we used a transconjunctival sutureless 25-gauge vitrectomy system (TSV), patients in group 2 (n=20) were operated on using a standard 20-gauge vitrectomy system. The ERM was removed and the internal limiting membrane (ILM) was peeled in all eyes. Surgery-related complications, operating time, intraoperative balanced salt solution (BSS) consumption, postoperative discomfort, postoperative intraocular inflammation, lens opacification, and long-term visual outcome are reported and compared.
No surgery-related complications were observed in either group. Operating time was shorter in group 1 compared with group 2 (mean 15.6 and 29.6 min respectively). Intraoperative amount of BSS consumption was less in group 1 (mean 28 ml in group 1 and 42 ml in group 2). Postoperative discomfort and intraocular inflammation were significantly reduced in the 25-gauge group. In the 20-gauge group cataract formation requiring surgery was observed in two eyes. Visual acuity improved significantly in both groups. The 25-gauge group improved on average by more lines of vision and the improvement in vision was more rapid.
The TSV system is a safe and efficient surgical technique for ERM surgery. Operating time is significantly reduced, minimizing surgery-induced trauma, and reducing postoperative intraocular inflammation and the patients' discomfort. The incidence of cataract formation may be less using TSV. Postoperative recovery is accelerated.
本研究旨在评估小切口无缝线玻璃体切除术治疗特发性视网膜前膜(ERM)的安全性和功能结果,并与标准的20G玻璃体切除术系统进行比较。
连续招募46例特发性ERM患者进行本研究并进行前瞻性评估。第1组(n = 26)使用经结膜无缝线25G玻璃体切除术系统(TSV),第2组(n = 20)患者使用标准20G玻璃体切除术系统进行手术。所有患眼均切除ERM并剥除内界膜(ILM)。报告并比较手术相关并发症、手术时间、术中平衡盐溶液(BSS)消耗量、术后不适、术后眼内炎症、晶状体混浊和长期视力结果。
两组均未观察到手术相关并发症。第1组的手术时间比第2组短(分别平均为15.6分钟和29.6分钟)。第1组术中BSS消耗量较少(第1组平均28毫升,第2组平均42毫升)。25G组术后不适和眼内炎症明显减轻。在20G组中,有两只眼观察到需要手术的白内障形成。两组视力均有显著改善。25G组平均视力改善的行数更多,视力改善更快。
TSV系统是一种用于ERM手术的安全有效的手术技术。手术时间显著缩短,将手术引起的创伤降至最低,并减少术后眼内炎症和患者不适。使用TSV可能降低白内障形成的发生率。术后恢复加快。